Evaluation of the bases of permission and prohibition of therapeutic cloning in Iran and the United States of America

Document Type : Original Article

Authors

1 PhD Student in Private Law,, Faculty of Law, Theology and Political Science and Research Unit, Islamic Azad University , Tehran, Iran

2 Former Visiting Professor at Faculty of Law, Theology and Political Sciences, Science and Research Unit, Islamic Azad University, tehran, Iran and professor at Department of Public Law and Economic Law, Faculty of Law, Shahid Beheshti University, Tehran, Iran

3 Associate Professor of Law Faculty of Intrnational Trade Law, Intellectual Property Law and Cyberspace, Faculty of Law, Shahid Beheshti University,,Tehran, Iran

4 Professor at Department of International Law,, Faculty of Law, Shahid Beheshti University,,Tehran, Iran

10.48308/jlr.2023.224781.2049

Abstract

The scientific method of therapeutic cloning, which claims to cure many incurable diseases, has been challenged by many moral thinkers and lawyers since its inception; On the other hand, the supporters of this method of treatment believe in its legitimacy due to its many benefits and advantages. Regardless of the opposition or agreement with therapeutic cloning in the legal system of each country, explaining the principles and bases of the supporters and opponents of this scientific method is of greater importance. The analysis and evaluation of the principles and bases cited by the proponents and opponents of therapeutic cloning shows that due to the equating of the state of the embryo resulting from the therapeutic cloning process with a human embryo by the opponents, their oppositions and arguments are not based on a correct foundation. Also, according to new scientific research, scientists have been able to find new solutions to prevent the abuse of this treatment method by solving the concerns of the opponents. Researches that are based on the necessity of the progress of science and the development of medical and therapeutic sciences.

Keywords

Main Subjects



Articles in Press, Accepted Manuscript
Available Online from 05 February 2025
  • Receive Date: 02 December 2021
  • Revise Date: 31 January 2023
  • Accept Date: 05 March 2023